Dryvax Dilution-Prev Vacc Adults

Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

NCT00053495 ·Status: COMPLETED ·Phase: PHASE2

Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

NCT00053508 ·Status: TERMINATED ·Phase: PHASE2

Immune Responses to Smallpox Vaccination

NCT00325975 ·Status: COMPLETED

Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®

NCT00042094 ·Status: COMPLETED ·Phase: PHASE1

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

NCT00053742 ·Status: COMPLETED ·Phase: PHASE1

ACAM 3000 MVA at Harvard Medical School

NCT00133575 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Combination Study With MVA BN and Dryvax

NCT00082446 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers

NCT00103584 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age

NCT03314103 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

NCT00389103 ·Status: WITHDRAWN ·Phase: PHASE1

A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers

NCT01375933 ·Status: COMPLETED ·Phase: PHASE3

Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT

NCT00038987 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine

NCT00466245 ·Status: COMPLETED ·Phase: PHASE2

Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.

NCT00189956 ·Status: COMPLETED ·Phase: PHASE2

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat

NCT02474589 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

NCT00079820 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects

NCT00316524 ·Status: COMPLETED ·Phase: PHASE2

A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children

NCT02965404 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

NCT00857493 ·Status: COMPLETED ·Phase: PHASE2

High Dose IMVAMUNE® in Vaccinia-Naive Individuals

NCT00879762 ·Status: COMPLETED ·Phase: PHASE2

Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally

NCT00914732 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years

NCT05762523 ·Status: COMPLETED ·Phase: PHASE1

MVA Post-Event: Administration Timing and Boost Study

NCT00437021 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

NCT00534248 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders

NCT00189917 ·Status: COMPLETED ·Phase: PHASE1